I note the recent passing of Marshall Horwitz on 31 May 2005. Dr. Horwitz was an internationally recognized virologist who made important contributions to our understanding of adenoviruses, causative agents of respiratory, enteric, and opthalmologic infections. In the course of his career he studied many aspects of the biology of ...

I note the recent passing of Maurice Hilleman on 11 April 2005. Dr. Hilleman was a giant in the field of vaccines. Working at Merck & Co., he developed 8 of the 14 commonly used vaccines: measles, mumps, hepatitis A, hepatitis B, chickenpox, meningitis, pneumonia, and Haemophilus. Among his other ...

Yesterday was the 50th anniversary of the licensing of the first vaccine against poliomyelitis, the inactivated poliovaccine (IPV) developed by Jonas Salk. On 12 April 1955, the results of the clinical trial of IPV were announced. The trial, supported by the National Foundation for Infantile Paralysis (NFIP) and organized by ...

Influenza is an acute respiratory disease that occurs both in yearly outbreaks, or epidemics, and in much larger, global outbreaks called pandemics. Predicting the next pandemic strain is an important goal because advance preparation of a vaccine could save many lives. The outbreaks of avian influenza in east and southeast ...

This past week the vaccine against influenza made world news when the British government suspendend the manufacturing license of a Liverpool factory that produces the vaccine. The factory is owned by Chiron, which had hoped to sell influenza vaccine produced there in the U.S. As a consequence, the U.S. will ...